Homburger advised UBS Switzerland on the issuance of fixed rate covered bonds in aggregate amount of € 1 bn, under the institute’s covered bond programme. The SIX-listed bonds yeald 2.783 % and will mature in 2030. In connection with
Niederer Kraft Frey advised SMG throughout the draft of its prospectus and the start of the book-building process, in sight on the company’s IPO on SIX Swiss Exchange. In connection with the operation, Pestalozzi
Bär & Karrer advised the future Audi F1 Team on a multi-year partnership with Adidas. The German sporting goods manufacturer is thus set to become the team’s official apparel partner from the 2026 Formula 1
Vischer advised Medartis, an SIX-listed orthopedic company with headquarters in Basel specialising in head and extremity surgery, on its acquisition of the remaining 53% of Geneva-based KeriMedical. Pursuant to the deal, Medartis becomes the sole owner
Vischer advised selling part Carauktion in connection with AutoScout24’s take-over of the C2B business, developed jointly with Carauktion itself. Pursuant to the deal – which includes the C2B auction platform – the “AutoScout24
Homburger advised UBS Switzerland on the issuance of fixed rate covered bonds for an aggregate amount of CHF 510 million. The operation unfolded in two tranches – respectively of CHF 235 m at 0.560%, due 2030, and CHF 275 m at 0.935%,
Lenz & Staehelin advised BNP Paribas on the Swiss merger filing concerning BNP Paribas Cardif’s acquisition of AXA Investment Managers (AXA IM). BNP Paribas Cardif is the insurance subsidiary of BNP Paribas. The transaction,
Bär & Karrer advised ETH Zurich throughout enactment of a revised policy for the insitute’s spin-offs and start-ups, encompassing a dedicated Equity and Licensing Policy. The context Pursuant to the revised regulatory framework,
Spar Group completed the sale of its entire shareholding in Spar Holding – including its Swiss business operations Spar Switzerland – to Tannenwald Holding. In connection with the deal, Homburger advised the selling part, while Bär &
Vischer advised Schivo on its acquisition of Mecaplast, a Swiss manufacturer of high-precision injection-moulded plastics, metals and ceramics for the medical device and life sciences sectors. Schivo – the buyer – is a medtech contract developer and